RxDoctor Payments Data

Heidi McNaney Flint, MD

Gynecology · Stuart, FLNPI 1801805940

Payments from drug & device makers

$831in general payments, 2019–2025

Across 36 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$462
  • AMAG Pharmaceuticals, Inc.$70
  • Pfizer$69
  • Therapeuticsmd, Inc.$59
  • Duchesnay USA Incorporated$41
  • Exact Sciences$30
  • plus $101 from 5 others

What the payments were for

  • Food & beverage$76192%
  • Education$708%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$831 in reported general payments places this provider in the 45th percentile of 290 gynecology providers in Florida.

See all gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$508,022
Medicare patients
867
Services billed
16,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron22$24,323
PremarinEstrogens, Conjugated32$13,992
Estradiol167$8,395
PremproEstrogen,con/M-Progest Acet15$5,433
Estradiol (Twice Weekly)Estradiol31$3,667
DuaveeEstrogens,conj/Bazedoxifene13$2,919
ValacyclovirValacyclovir Hcl54$2,075
ProgesteroneProgesterone, Micronized44$1,824
Raloxifene Hcl34$1,780
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip91$1,634
Solifenacin Succinate30$1,197
Medroxyprogesterone Acetate35$1,079
Alendronate Sodium106$1,072
Estradiol (Once Weekly)Estradiol11$753
Mometasone Furoate26$664

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin, Prempro, Duavee$69$22,34460 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 290 gynecology providers in Florida.

Other gynecology in Stuart

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →